← all works
RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients with Chronic HBV Infection
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Post-publication record
OpenAlex flags this work as retracted, but it carries no matching Retraction Watch record in this frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Clinical Gastroenterology and Hepatology
- Topic
- Hepatitis B Virus Studies
- Field
- Medicine
- Canadian institutions
- Toronto General HospitalCanadian Society of Intestinal Research
- Funders
- Gilead Sciences
- Keywords
- Tenofovir alafenamideMedicineBone mineralInternal medicineHBeAgBone remodelingGastroenterologyTenofovirHepatitis B virusFRAXUrologyOsteoporosisViral loadHBsAgHuman immunodeficiency virus (HIV)ImmunologyVirusOsteoporotic fracture
- Has abstract in OpenAlex
- no